Sebastian Böltz

9PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Mixed initiative and human-in-the-loopHaematological tumoursNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

|Jan 07, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Fabian Müller, Melanie Hagen, Andreas Wirsching

|Apr 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

Fabian Müller, Andreas Wirsching, Melanie Hagen

|Oct 13, 2022
Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.

Felix Muehlensiepen, Susann May, Katharina Hadaschik

|Sep 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Andreas Mackensen, Fabian Müller, Dimitrios Mougiakakos

|Aug 19, 2018
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation.

Elmar Pieterse, Nils Rother, Cansu Yanginlar

Pageof 2

Frequent Collaborators

7 joint publications

Georg Schett

5 joint publications

Andreas Mackensen

4 joint publications

Fabian Müller

3 joint publications

Maria Gabriella Raimondo